Get more replies from employers
Send a job-specific resume in minutes.
Regeneron Pharmaceuticals seeks a Senior Clinical Data Manager to lead data management activities across multiple trials, from start‑up to archiving, ensuring timely, on‑budget delivery with stringent regulatory adherence.
You will serve as the study DM lead and POC for clinical study teams and CROs, providing expert guidance in eCRF design, data quality, transfers, and database lock, while mentoring virtual teams in a matrix environment.
The Senior Clinical Data Manager will serve as the DM study lead and point of contact for clinical study teams and external partners for multiple trials within a given Therapeutic Area (TA). Lead all aspects of DM activities across all stages of the trial from study start‑up through archiving to achieve data management results within the assigned drug assets and goals to ensure timely completion within project budget guidelines and adhering to all applicable policies and procedures.
We have an inclusive and diverse culture that provides comprehensive benefits, which often include (depending on location) health and wellness programs, fitness centers, equity awards, annual bonuses, and paid time off for eligible employees at all levels.
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. The Company will also provide reasonable accommodation to the known disabilities or chronic illnesses of an otherwise qualified applicant for employment, unless the accommodation would impose undue hardship on the operation of the Company’s business.